Surgery emerges as a viable treatment for stage IE primary thyroid lymphoma (PTL), with a cohort study of 1,596 patients (SEER database) and an external cohort of 38 patients (Shanghai, China). The 7.8-year SEER analysis showed no significant survival difference between surgery, surgery + radiotherapy/chemotherapy, and radiotherapy/chemotherapy alone. In the external cohort, surgery-alone exhibited comparable disease-specific survival, lower complications, shorter treatment duration, and reduced costs compared to radiotherapy/chemotherapy.
Journal Article by Tang Y, Yan T (…) Yang Z et 4 al. in Ann Surg Oncol
© 2023. Society of Surgical Oncology.